Calidi Biotherapeutics

Calidi Biotherapeutics is thrilled to announce FDA Clearance of the Northwestern University IND Application for Calidi's NeuroNova (CLD-101) Clinical Trial in Newly Diagnosed High-Grade Glioma. Congratulations to the NWU and Calidi teams! Read more below: #calidi #IND #clinicaltrial #virotherapy #neuronova $CLDI #glioblastoma #highgradeglioma #braincancer

Missed Our Virtual Presentation? Watch the Replay Now! Yesterday, we at Calidi Biotherapeutics hosted an exciting virtual presentation diving deep into the groundbreaking science and innovative technology we’re developing to combat cancer. If you missed it, don’t worry! You can catch the full replay and discover how our pioneering approaches are transforming the future of cancer treatment. Watch the Replay Here:?https://lnkd.in/gnGR7Fmf Join us on this journey towards a world free from the threat of cancer. Your support and curiosity drive our mission forward! #CalidiBio #CancerResearch #Biotechnology #Innovation #Science #Healthcare

Join Us for an Exciting Webinar: Calidi’s Groundbreaking Cancer Treatment ???Date: September 11th ? ???Time: 4:15 PM ET Discover the future of cancer treatment with Calidi! Our developmental drug targets and destroys cancer cells throughout the body while leaving healthy cells unharmed. Don’t miss this opportunity to learn more about this revolutionary therapy. ???Register now: #calidi #virotherapy #endcancer $CLDI

Calidi Biotherapeutics?was recently featured in an article by?Fred Grier?with the?San Diego Business Journal, highlighting the launch of our new subsidiary, Nova Cell. Read more below! #calidi #novacell #stemcells #biotech #sandiego $CLDI

?? Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results. Read more below! #calidi #virotherapy #stemcells #biotech $CLDI

Calidi Biotherapeutics is proud to announce the launch of our new subsidiary, Nova Cell, and a $3 million aggregate investment from Dr. Ronald Rigor. Dr. Rigor, an accomplished Board-Certified Dermatologist, Internal Medicine, and Stem Cell Therapy expert has taken a significant step to advance regenerative medicine by investing in Nova Cell. “As the founder of one of the largest and fastest growing stem cell centers in the Philippines, I am delighted to partner with and invest in Nova Cell. This is a fantastic opportunity to provide best-in-class stem cell therapy treatments which could meet a huge unmet need in the Philippines. We look forward to bringing Nova Cell’s extensive experience in stem cell therapy production to provide innovative therapies to patients and to elevate the health and wellness industry in the Philippines.” - Dr. Rigor Read more below: #stemcell #calidi #NovaCell $CLDI

Calidi Biotherapeutics recently announced the issuance of a new U.S. patent covering our novel SuperNova technology! “This latest patent granted to Calidi covering meaningful features of our SuperNova platform represents an important milestone, as we prepare to advance CLD-201 into the clinic." - Allan Camaisa, CEO and Chairman. Read more below: #calidi #patent #SuperNova #virotherapy #stemcells $CLDI

Calidi Biotherapeutics Chief Scientific Officer, Antonio F. Santidrian. Ph.D., was recently featured in an article by Cell & Gene, where he highlights Calidi's ability to utilize stem cells as "an immunologic Trojan Horse." Thank you for the coverage Tyler Menichiello on our important cancer immunotherapy work. Read more below: #calidi #cellandgene #trojanhorse #immunotherapy #virotherapy

?? Calidi Biotherapeutics is thrilled to welcome Dr. Mark Gilbert to our Medical Advisory Board. “What intrigued me about Calidi’s SNV1 and NNV1 is its versatility and ability to?potentially address rare cancer diseases affecting about 25% of cancer patients.” - Dr. Gilbert Read more below: #calidi #endcancer #virotherapy #stemcells $CLDI

Calidi Biotherapeutics is excited to share our new broadcasted television commercial, which is being aired throughout the week on CNBC. Thank you to the Calidi Team for your continued hard work and dedication. #calidi #endcancer #virotherapy #RTNova #cnbc $CLDI